Presentation on theme: "Update on VA Human Specimen Research and Tissue Banking"— Presentation transcript:
1Update on VA Human Specimen Research and Tissue Banking Marianna J. Bledsoe, M.A.Senior Program Manager for Biorepositories and BiobankingOffice of Research and DevelopmentJune 27, 2012
2Note: To see the answers to the survey questions, you must view this as a PowerPoint slide show. There are no “correct” answers for this presentation. This was a poll.
3Overview Introduction Audience response questions Applicable federal regulationsRelevant VA policiesVA guidelinesOther Considerations for ACOS/R&D and AO
4For ACOS Only: Do you currently have approved research projects involving human specimens research at your facility?YesNoUnknown
5For ACOS Only: Do you have human “tissue banks*” at your facility? YesNoUnknown*For the purposes of this presentation, a tissue bank is a repository of specimens established and maintained for the purposes of secondary or future research.
6For ACOS only: Do investigators at your facility have projects in which specimens are banked off-site?YesNoUnknown
7For ACOS only: If you answered yes to the preceding question, where are the specimens located? Academic affiliateOther location other than academic affiliateBoth of the aboveUnknown
8TIME Magazine’s Top 10 Ideas Changing the World Right Now Jobs Are the New AssetsRecycling the SuburbsThe New CalvinismReinstating The InterstateAmortalityAfrica: Open for BusinessThe Rent-a-CountryBiobanksSurvival StoresEcological IntelligenceMarch 16, 2009 Issue
10Federal Regulations and Policies Related to Human Specimen Research
11Applicable Federal Regulations May Include: Common Rule: 38 CFR part 16FDA Regulations:21 CFR Part 50, 56, 812HIPAA Privacy and Security Rules:45 CFR Part 160; Subparts A, C & E of Part 164Privacy Act of 1974HITECH Breach Notification Interim Final RuleProvide links in the handouts
12When is Specimen Research Human Subjects Research According to the Common Rule? Is it research?Research means a systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.OHRP considers creation of repositories for research purposes/tissue banks a research activity
13When is Specimen Research Human Subjects Research According to the Common Rule? Is it human subjects research?Human subject – A living individual about whom an investigator (whether professional or student) conducting research obtains a) data through intervention or interactions with the individual, or b) identifiable private information. [38 CFR (f)]Common Rule definition of identifiable = the identity of the subject is or may readily be ascertained by the investigator or associated with the information
14Three paths to human subjects research under 38 CFR part 16: When is research involving a tissue bank human subjects research according to the Common Rule?Three paths to human subjects research under 38 CFR part 16:Creating a research tissue bank through intervention or interaction with individualCreating a research tissue bank by obtaining identifiable private informationObtaining identifiable private information from a research tissue bank
15Is research using “coded” specimens human subjects research according to the Common Rule? It depends.
16OHRP Guidance on Coded Private Information or Biological Specimens Definition of “Coded”:(1) identifying information (such as name or social security number) that would enable the investigator to readily ascertain the identity of the individual to whom the private information or specimens pertain has been replaced with a number, letter, symbol, or combination thereof (i.e., the code); and(2) a key to decipher the code exists, enabling linkage of the identifying information to the private information or specimens.
17OHRP Guidance on Coded Private Information or Biological Specimens “In general, OHRP considers private information or specimens to be individually identifiable as defined at 45 CFR (f) when they can be linked to specific individuals by the investigator(s) either directly or indirectly through coding systems.”However, the OHRP coded specimens policy allows exceptions under certain conditions.
18OHRP Guidance on Coded Private Information or Biological Specimens Research involving only coded information or specimens is not considered to involve human subjects if the following conditions are both met: (1) the private information or specimens were not collected specifically for the currently proposed research project through an interaction or intervention with living individuals; AND (2) the investigator(s) cannot readily ascertain the identify of the individual(s) to whom the coded private information or specimens pertain.
19OHRP Guidance on Coded Private Information or Biological Specimens Examples of When Coded Data/Biologic Specimens Are Not Individually Identifiable to Investigators: (a) the investigators and the holder of the key enter into an agreement prohibiting the release of the key to the investigators under any circumstances, until the individuals are deceased
20OHRP Guidance on Coded Private Information or Biological Specimens Examples of When Coded Data/Biologic Specimens Are Not Individually Identifiable to Investigators:(b) there are IRB-approved written policies and operating procedures for a repository or data management center that prohibit the release of the key to the investigators under any circumstances, until the individuals are deceased; or(c) there are other legal requirements prohibiting the release of the key to the investigators, until the individuals are deceased.
21OHRP Guidance on Coded Private Information or Biological Specimens Only applies if: 1. Person(s) doing coding of data/specimens and person(s) holding codes are not part of the research team; AND 2. Specimens/data are not being obtained for the specific research in question by an interaction or intervention with living individuals.
22Review of VA Human Specimen Research When human specimens are used in VA research, the research must be included as part of a protocol that is reviewed and approved by the VA R&D Committee.If the research involving human specimens is human subjects research according to the Common Rule or FDA regulations, the research must also be reviewed and approved by an IRB.
23VA Specimen ResearchCurrent guidelines found on ORD web siteVHA Handbook on specimen research/tissue banking currently under development
24Relevant VA PoliciesVHA Handbook Requirements for the Protection of Human Subjects in ResearchVHA Handbook —Use of Data and Data Repositories in VHA ResearchVHA Handbook Privacy and Release of InformationVHA Handbook —Minimum Necessary Standard for Protected Health InformationVA Handbook Information Security ProgramVHA Handbook —Pathology and Laboratory Medicine Service Procedures
26Case Example #1An investigator is collaborating with a drug company that is collecting specimens as part of an industry sponsored trial. The drug company will be performing analyses for the main study, but will be retaining specimens less than 90 days.
27Is an off-site waiver from ORD needed? YesNoDon’t Know
28Case Example #2An investigator is collaborating with a drug company that is collecting specimens as part of an industry sponsored trial. The drug company will be performing analyses for the main study, and will be storing the specimens for the entire length of the study (5 years).
29Is an off-site waiver from ORD needed? YesNoDon’t Know
30Case Example #3An investigator is collaborating with a drug company that is collecting specimens as part of an industry sponsored trial. The drug company will be performing analyses for the main study, and wishes to bank the specimens beyond the end of the study protocol for future unspecified research.
31Is this permitted by current VA guidelines? YesNoDon’t Know
32Specimens for a Single Research Protocol A waiver from ORD must be obtained if:If specimens are stored off-site at a non-profit institution 5 yearsIf specimens are stored off-site at a non-academic, for-profit institution for >3 monthsIf the specimens are sent to a non-VA institution for testing as defined in the protocol, once the specific analyses are performed, the remainder of the specimens must be destroyed or returned to the VA for destruction.
33Collecting and Storing Specimens for Secondary or Future Research (“Tissue Banking”) A tissue bank established at a VA site by a VA-paid investigator does not require ORD approval.The ACOS/R or research office should be aware of all tissue banks within the facility.
34Collecting and Storing Specimens for Secondary or Future Research The researcher must obtain a waiver from ORD before banking human biological specimens for future research use at an off-site location.Specimens may not be banked for future research use at a non-academic, for-profit institution.Off-site tissue banks are approved on a per protocol basis.
35Collecting and Storing Specimens for Secondary or Future Research Exception: Some National Cancer Institute (NCI)-sponsored tissue banks are exempt from the requirements as a result of a memorandum of understanding with the NCI. Protocols that involve collection for these banks do not require ORD approval. (See list on VA tissue banking website)
36Storage of SpecimensSpecimens must be labeled with a code that does not contain any of the 18 HIPAA identifiers.In the case of storage at non-profits, the key to the code must be maintained at the VA unless there is a compelling reason otherwise. If the storage is at a for-profit institution, then it is mandatory that the code be maintained at the VA.
37Additional Requirements for Specimens Stored at For-Profit Sites Only analyses/tests listed in the protocol and informed consent may be performed.The code must be maintained at the VAMC.All specimens must be de-identified to meet both Common Rule and HIPAA requirements.Limited DNA/RNA analyses may be performed.
38Additional Requirements for Specimens Stored at For-Profit Sites (Cont’d) Use of initials outside of VA is generally not permitted.Specimens must be destroyed within 1 year of the study completion date. The company should inform the PI in writing when samples are destroyed.
39Application Process for All Off-site Waivers The investigator must complete VA form (http://www.va.gov/vaforms/medical/pdf/vha fill.pdf).The following additional is required:Research protocolTissue bank manual/SOPs [non-profits]VA consent formHIPAA authorizationThe application should be ed to Kristina Hill It should be sent from the research office.Alternatively, the form and requested information can be faxed to: (202)
40Application Process for All Off-site Waivers After the application is reviewed, the PI and ACOS/R will receive a memo listing any issues that need to be addressed.Frequent issues with all waiver applications include informed consent issues and use of identifiers.Frequent issues with waivers for off-site storage at for-profits include requests for long term storage and mandatory banking or genetic testing which is not permissible except when integral to study design.
41Multi-Site TrialsIf several VAMCs are planning to participate in the same clinical trial, then only one of the VA sites needs to apply for an off-site storage waiver.
43CustodianshipVA investigators and their facilities have a caretaking responsibility for the management of specimen collections.Includes tracking of documentation, ensuring that policies are in place and implemented appropriately, establishing agreements when specimens are transferred to third parties, and ensuring that specimens are appropriately disposed of when the collection is no longer scientifically useful or can no longer be maintained.
44CustodianshipA VA investigator should be designated as the custodian of specimen collections in the protocol that is reviewed and approved by the R&D Committee. (Requirement for off-site storage waiver).Physical safeguards and policies should be in place to restrict access to only authorized individuals who need access to perform their duties under the approved research protocol.
45CustodianshipSpecimens should only be transferred outside of VA when such transfers are consistent with the R&D Committee and IRB-approved protocol and informed consent and there are appropriate agreements in place that define the responsibility of the specimen recipients.Material Transfer Agreements (MTAs), Cooperative Research and Development Agreements (CRADAs), or other contractual agreements that define the responsibilities of the recipient
46Material Transfer Agreements Address:Appropriate use of specimens (consistent with protocol and informed consent, etc.)Human subjects protectionsSharing of specimens with third partiesCommercial use of specimensBiohazardsIndemnification
47Need to address custodianship issues: Special Considerations When Specimens Are Collected For Storage and Distribution for Future Research (“Tissue Banking”)Need for review and oversight of tissue bank operating procedures and policies for protecting subject privacy and confidentiality, access and disseminationNeed for mechanism for ensuring specimen use is consistent with informed consentNeed to address custodianship issues:Material Transfer Agreements; CRADAsPlans if repository/bank loses support or is no longer scientifically usefulPlans for transfer if PI leaves institution
48Current Hot Topics Return of Research Results and Incidental Findings Topic of considerable controversy, especially in the context of tissue bankingGroup HarmsIdentifiabilityDiffering definitionsImpact of emerging genetic technologies and extent and availability of databases containing patient/subject information
49Stay Tuned: Change is On the Way VHA Handbook currently under developmentCurrent VA guidelines may changeCommon Rule may changeMore to come!
50Resources and Best Practices See handouts on meeting website:Regulations, Policies and Educational Documents Related to Human Specimen ResearchResources and Tools Related to Human Specimen Research2012 Best Practices for Repositories: Collection, Storage, Retrieval, and Distribution of Biological Materials for Research. International Society for Biological and Environmental Repositories; Biopreservation and Biobanking, 10(2), 2012.National Cancer Institute Best Practices for Biospecimen Resources,